Palisade Bio (PALI) Total Debt Growth (1y) (2014 - 2025)
Powered by 
Analysis
Palisade Bio (PALI) Total Debt Growth (1y) (2014 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 0.10% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 12.42% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 3.78% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 0.00% |
| 10 | Palisade Bio | 440.73 Mn | 315.53 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -55.70% |
| Mar 31, 2025 | -51.75% |
| Dec 31, 2021 | -92.05% |
| Mar 31, 2017 | -27.64% |
| Dec 31, 2016 | -5.75% |
| Sep 30, 2016 | -5.37% |
| Jun 30, 2016 | 7.67% |
| Mar 31, 2016 | -21.07% |
| Dec 31, 2015 | -9.77% |
| Sep 30, 2015 | 60.20% |
| Jun 30, 2015 | 41.05% |
| Mar 31, 2015 | 26.15% |
| Dec 31, 2014 | -3.60% |
| Sep 30, 2014 | -36.72% |
| Jun 30, 2014 | -22.65% |
| Mar 31, 2014 | -11.95% |